Short-and Long-Term Follow-up in the Elderly Patients with ST-Elevation Myocardial Infarction Receiving Primary Angioplasty or Thrombolytic Therapy

Authors

Mohammad Kazem Kazemi1, Khalil AlimohammadzadehKhalil Alimohammadzadeh ORCID2, 3,*, Ali Maher4
1Department of Health Services Management, North Tehran Branch, Islamic Azad University, Tehran, Iran
2Associate Professor, Department of Health Services Management, North Tehran Branch, Islamic Azad University, Tehran, Iran
3Health Economics Policy Research Center, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
4Ph.D. in Health care Administration, Fellowship in Health Financing, North Tehran Branch, Islamic Azad University, Tehran, Iran
*Corresponding Author: Corresponding author: M.D., Ph.D., Department of Health Services Management, North Tehran Branch, Islamic Azad University, Tehran, Iran. Tel: +98-2122614827, E-mail: Email: [email protected]

International Journal of Cardiovascular Practice:Vol. 4, issue 1; 10-15
Published online:Mar 16, 2019
Article type:Research Article
Received:Aug 12, 2018
Accepted:Oct 05, 2018
How to Cite:Kazemi MK, Alimohammadzadeh K, Maher A. Short-and Long-Term Follow-up in the Elderly Patients with ST-Elevation Myocardial Infarction Receiving Primary Angioplasty or Thrombolytic Therapy. Int J Cardiovasc Pract. 2019;4(1):e130287. doi: https://doi.org/10.21859/ijcp-403

Abstract

Introduction: The ischemic time serves as the most important parameter for treatment choice in patients with ST-elevation myocardial infarction (STEMI). The current study aimed at comparing the short- and long-term follow-up of elderly patients with STEMI undergoing primary angioplasty (PCI) or thrombolytic therapy.

Methods: The current cross sectional study was conducted on all patients aged > 65 years, admitted to the emergency department of Imam Hossein Hospital, Tehran, Iran from January 2014 to July 2016, diagnosed with STEMI. The demographics, medical history, family history, and mediation history were recorded for all patients. Patients received PCI or thrombolytic therapy based on the ischemic time and the treatment outcome and the following events were recorded. Patients were contacted after six months and data of their death or used treatments were recorded. All data were compared between the groups.

Results: Of all patients, 38 subjects received thrombolytic therapy and 62 PCI. There was no significant difference between the groups in terms of mean age and gender (P = 0.5 and 0.1, respectively). The frequency of positive medical history and smoking did not differ between the groups. There was no difference in the mean values of vital signs or serum parameters, mean ischemic time, left ventricular ejection fraction (LVEF), frequency of pulmonary emboli, cardiogenic shock, the involved vessel, and posttreatment complications between the groups (P > 0.05). Of the 14 cases that died after six months, five were in the thrombolytic therapy group and nine in the PCI group (P = 0.8). Mean hospital stay was not different between the groups (P = 0.5).

Conclusions: The results of the present study on two groups with similar demographics showed no significant difference between the groups in terms of the short- and long-term follow-up of PCI and thrombolytic therapy. The results indicated the appropriateness of treatment choice based on ischemic time and the available methods

Fulltext

Full-text is available in PDF file.

Copyright

© 2019, International Journal of Cardiovascular Practice. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

2
Aug
2016

In-hospital and late outcome of rescue versus primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction

Hossein Vakili,
Roxana Sadeghi,
Solmaz Borjian,
Naser Kachoueian

Vakili H, Sadeghi R, Borjian S, Kachoueian N. In-hospital and late outcome of rescue versus primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Int J Cardiovasc Pract. 2016;1(2):e130035. doi: https://doi.org/10.20286/ijcp-010203

30
Jun
2011

A Comparison of Outcomes of Routine Early Angiography versus Delayed Ischemia-Guided Angiography after Thrombolytic Therapy in ST Segment-Elevation Myocardial Infarction

HA Basiri,
Reza Kiani,
S Abdi,
A Zahedmehr,
HR Sanati,
F Shakerian
,et al.

Basiri H, Kiani R, Abdi S, Zahedmehr A, Sanati H, et al. A Comparison of Outcomes of Routine Early Angiography versus Delayed Ischemia-Guided Angiography after Thrombolytic Therapy in ST Segment-Elevation Myocardial Infarction. Int Cardiovasc Res J. 2017;5(2):e13996. doi:

17
Jul
2017

Short-term Cost-effectiveness of Reteplase versus Primary Percutaneous Coronary Intervention in Patients with Acute STEMI a Tertiary Hospital in Iran

Khalil Alimohammadzadeh,
Roxana Sadeghi,
Ali Maher,
Mohammad Kazem Kazemi

Alimohammadzadeh K, Sadeghi R, Maher A, Kazemi MK. Short-term Cost-effectiveness of Reteplase versus Primary Percutaneous Coronary Intervention in Patients with Acute STEMI a Tertiary Hospital in Iran. Int J Cardiovasc Pract. 2017;2(3):e130070. doi: https://doi.org/10.21859/ijcp-020305

14
Jun
2014

Effect of Streptokinase on Short-term Outcomes in the Acute Myocardial Infarction with ST-Segment Elevation

Awat Feizi,
Ali Nasr,
Hamid Sanei,
Peyman Mikaili,
Afshin Amirpoor,
Navab Ghasemi

Feizi A, Nasr A, Sanei H, Mikaili P, Amirpoor A, et al. Effect of Streptokinase on Short-term Outcomes in the Acute Myocardial Infarction with ST-Segment Elevation. J Rep Pharm Sci. 2014;3(1):e147731. doi:

20
Oct
2024
Comparative Analysis of Ticagrelor and Clopidogrel Effects on Medication Adherence, Adverse Events, and Laboratory Parameters in Iranian Acute Coronary Syndrome Patients Post-PCI

Comparative Analysis of Ticagrelor and Clopidogrel Effects on Medication Adherence, Adverse Events, and Laboratory Parameters in Iranian Acute Coronary Syndrome Patients Post-PCI

Vida Hamrahi,
Mehdi Pishgahi,
Alireza Javan,
Roya Hamrahi,
Mohamad Esmail Ghaidari

Hamrahi V, Pishgahi M, Javan A, Hamrahi R, Ghaidari ME. Comparative Analysis of Ticagrelor and Clopidogrel Effects on Medication Adherence, Adverse Events, and Laboratory Parameters in Iranian Acute Coronary Syndrome Patients Post-PCI. Int J Cardiovasc Pract. 2024;9(2):e150332. doi: https://doi.org/10.5812/intjcardiovascpract-150332

More by these authors

Mohammad Kazem KazemiPubMedScholar
Khalil AlimohammadzadehPubMedScholar
Ali MaherPubMedScholar
Share
Cited by
Metrics